Bullish Case: Multi-year base breakout persists: call volume leads puts 49%,Helium density peaks near $175 with substantial mass at $150-170,and market density peaks at $175. Flat term structure (~34-36% IV) with rich left-skew makes upside convexity cheap. Raised FY26 guidance and Biocare integration support momentum toward $185-200.

Bearish Case: At 7.9x book after a massive rally,valuation is stretched and Helium's own AI forecast is -0.89% with 0.1 correlation. Deep left-skew persists: Nov 145P at 51.8% IV and near-term term structure shows backwardation (Nov 44% vs Dec 36%),implying near-term fear. Sub-$140 has meaningful probability mass in Helium's density.

Potential Outcomes:

1) 35%: Consolidation $150-165 into Jan as post-earnings digestion; IV stays flat.

2) 30%: Bull continuation to $170-185; call flow sustains re-rating; falsified if $155 breaks.

3) 20%: Pullback to $135-150; skew resolves lower with Q4 report.

4) 10%: Sharp correction <$135; macro rotation or guidance miss.

5) 5%: M&A/strategic surprise >$200.

November 03, 2026